Prognostic impact of metastatic sites for pembrolizumab efficacy as first-line therapy in patients with PD-L1 tumour proportion score (TPS) ≥ 50% advanced non-small cell lung cancer: A retrospective multicenter study
H. Kawachi
◽
M. Tamiya
◽
A. Tamiya
◽
S. Ishii
◽
K. Hirano
◽
...
2018 ◽
Vol 29
◽
pp. viii545
◽
F. Wu
◽
G. Gao
◽
C. Zhou
◽
X. Kang
◽
Y. Zhou
Bruno Andreoni
◽
Gianmarco Contino
2021 ◽
Vol 16
(4)
◽
pp. S759
E. Marcella
◽
B. Susanto
◽
S. Chen
◽
J. Tandiono
◽
A. Tancherla
◽
...
2007 ◽
Vol 5
(4)
◽
pp. 363
◽
G. Scagliotti
◽
K. Park
◽
S. Patil
◽
J. Rolski
◽
T. Gorksel
◽
...
2021 ◽
Vol 24
◽
pp. S65-S66
R. Veluswamy
◽
G. Barnes
◽
R. Strauss
◽
D. Harrough
◽
B. Tang
2013 ◽
Vol 108
(2)
◽
pp. 265-270
◽
A Atmaca
◽
S-E Al-Batran
◽
D Werner
◽
C Pauligk
◽
T Güner
◽
...
2016 ◽
Vol 7
(11)
◽
pp. 1515-1523
◽
Yi-Hsin Liang
◽
Yu-Yun Shao
◽
Bin-Chi Liao
◽
Ho-Sheng Lee
◽
James Chih-Hsin Yang
◽
...
2013 ◽
Vol 8
(4)
◽
pp. 443-451
◽
Thomas E. Stinchcombe
◽
Joanna Roder
◽
Amy H. Peterman
◽
Julia Grigorieva
◽
Carrie B. Lee
◽
...
2018 ◽
Vol 125
◽
pp. 273-281
◽
Shirish M. Gadgeel
◽
James P. Stevenson
◽
Corey J. Langer
◽
Leena Gandhi
◽
Hossein Borghaei
◽
...
Yi Chen
◽
Jinyu Li
◽
Shixue Chen
◽
Yibao Zhang
◽
Yi Hu
◽
...
Close
Export Citation Format
Close
Share Document
Close